Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,900 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term efficacy and safety of the small-sized β2-microglobulin adsorption column for dialysis-related amyloidosis.
Yamamoto Y, Hirawa N, Yamaguchi S, Ogawa N, Takeda H, Shibuya K, Kawahara K, Kojima H, Dobashi Y, Fujita M, Azusima K, Miyazaki N, Kobayashi M, Kobayashi C, Fujiwara A, Yuto J, Saka S, Yatsu K, Toya Y, Yasuda G, Ohnishi T, Umemura S. Yamamoto Y, et al. Among authors: ohnishi t. Ther Apher Dial. 2011 Oct;15(5):466-74. doi: 10.1111/j.1744-9987.2011.00937.x. Epub 2011 May 25. Ther Apher Dial. 2011. PMID: 21974700
Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
Kokuho T, Toya Y, Kawaguchi Y, Tamura K, Iwatsubo K, Dobashi Y, Nakazawa A, Takeda H, Iwatsubo M, Hirawa N, Yasuda G, Ohnishi T, Umemura S. Kokuho T, et al. Among authors: ohnishi t. Ther Apher Dial. 2007 Dec;11(6):442-8. doi: 10.1111/j.1744-9987.2007.00524.x. Ther Apher Dial. 2007. PMID: 18028171 Clinical Trial.
Effect of losartan on ambulatory short-term blood pressure variability and cardiovascular remodeling in hypertensive patients on hemodialysis.
Mitsuhashi H, Tamura K, Yamauchi J, Ozawa M, Yanagi M, Dejima T, Wakui H, Masuda S, Azuma K, Kanaoka T, Ohsawa M, Maeda A, Tsurumi-Ikeya Y, Okano Y, Ishigami T, Toya Y, Tokita Y, Ohnishi T, Umemura S. Mitsuhashi H, et al. Among authors: ohnishi t. Atherosclerosis. 2009 Nov;207(1):186-90. doi: 10.1016/j.atherosclerosis.2009.04.005. Epub 2009 Apr 11. Atherosclerosis. 2009. PMID: 19423110 Clinical Trial.
Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients.
Kawai Y, Toya Y, Wakui H, Fujikawa T, Ueda E, Azushima K, Kinguchi S, Mitsuhashi H, Kawano T, Kuji T, Yamaguchi S, Ohnishi T, Tamura K. Kawai Y, et al. Among authors: ohnishi t. J Pharmacol Sci. 2021 Sep;147(1):118-125. doi: 10.1016/j.jphs.2021.05.010. Epub 2021 Jun 12. J Pharmacol Sci. 2021. PMID: 34294362 Free article.
Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis Patients.
Kanai D, Wakui H, Haze T, Azushima K, Kinguchi S, Kanaoka T, Toya Y, Hirawa N, Kato H, Uneda K, Watanabe F, Hanaoka K, Hanaoka M, Mitsuhashi H, Yamaguchi S, Ohnishi T, Tamura K. Kanai D, et al. Among authors: ohnishi t. Kidney Int Rep. 2022 Dec;7(12):2718-2721. doi: 10.1016/j.ekir.2022.09.005. Epub 2022 Sep 11. Kidney Int Rep. 2022. PMID: 36120389 Free PMC article. No abstract available.
1,900 results